ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells
Pulmonary hemorrhage (PH) is a life-threatening manifestation of systemic autoimmunity caused by immune-mediated disruption of the alveolar capillary barrier. Despite high mortality, the molecular checkpoints that shift destructive inflammation toward protective immune regulation remain poorly defined. Here, using a pristane-induced PH mouse model, we identify interleukin-2-inducible T-cell…
A recent study has revealed that a deficiency in interleukin-2-inducible T-cell kinase (ITK) can provide protection against autoimmune pulmonary hemorrhage in mice. PH is a life-threatening condition that occurs when the immune system damages the alveolar capillary barrier in the lungs, leading to high mortality rates. Researchers used a pristane-induced PH mouse model to identify ITK as a crucial regulator of autoimmune lung injury.
When ITK was deficient in these mice (Itk⁻ / ⁻), they showed near-complete protection from PH and associated multiorgan injury. This was accompanied by a reduced number of proinflammatory monocytes and neutrophils, as well as an increased presence of Foxp3 + regulatory T cells (Tregs). The researchers found that transferring Tregs from the Itk⁻ / ⁻ mice to wild-type recipients also protected them from PH and suppressed systemic proinflammatory cytokines, suggesting that Tregs play a key role in tissue protection.
The mechanism behind this protection lies in the increased production of amphiregulin, a tissue repair mediator, in lung Tregs with ITK deficiency. Transcriptomic profiling revealed that ITK loss reprogrammed Tregs into a more metabolically and functionally enhanced state. This state was characterized by enrichment in oxidative phosphorylation, mTORC1, and STAT5 signaling, as well as tissue-repair programs.
These findings establish ITK as a regulator of the balance between pulmonary injury and reparative immunity. The study supports targeting the ITK axis in severe inflammatory lung disease, offering a potential new avenue for treatment.
Rewritten by urgent.news; may contain errors — check the original.